Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection

References

• Majhail NS, Farnia SH, Carpenter PA, Champlin RE, Crawford S, Marks DI, Omel JL, Orchard PJ, Palmer J, Saber W, et al. Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the american society for blood and marrow transplantation. Biol Blood Marrow Transplant 2015; 21:1863-9; PMID:26256941; http://dx.doi.org/10.1016/j.bbmt.2015.07.032
   PubMed Web of Science ®Google Scholar
• Komanduri KV, St John LS, de Lima M, McMannis J, Rosinski S, McNiece I, Bryan SG, Kaur I, Martin S, Wieder ED, et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood 2007; 110:4543-51; PMID:17671230; http://dx.doi.org/10.1182/blood-2007-05-092130
   PubMed Web of Science ®Google Scholar
• Ringhoffer S, Rojewski M, Dohner H, Bunjes D, Ringhoffer M. T-cell reconstitution after allogeneic stem cell transplantation: assessment by measurement of the sjTREC/betaTREC ratio and thymic naive T cells. Haematologica 2013; 98:1600-8; PMID:23585532; http://dx.doi.org/10.3324/haematol.2012.072264
   PubMed Web of Science ®Google Scholar
• Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012; 18:348-71; PMID:22178693; http://dx.doi.org/10.1016/j.bbmt.2011.12.519
   PubMed Web of Science ®Google Scholar
• Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, Wingard JR, Young JA, Boeckh MJ, Center for International B, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15:1143-238; PMID:19747629; http://dx.doi.org/10.1016/j.bbmt.2009.06.019
   PubMed Web of Science ®Google Scholar
• Young JH, Logan BR, Wu J, Wingard JR, Weisdorf DJ, Mudrick C, Knust K, Horowitz MM, Confer DL, Dubberke ER, et al. Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated Donors. Biol Blood Marrow Transplant 2016 Feb;22(2):359-70; http://dx.doi.org/10.1016/j.bbmt.2015.09.013
   Web of Science ®Google Scholar
• Pasquini MC, Zhu X. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2015. Available at: http://www.cibmtr.org. 2015.
   Google Scholar
• Socie G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, Cahn JY, Passweg JR, Rowlings PA, Schouten HC, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late effects working committee of the international bone marrow transplant registry. N Engl J Med 1999; 341:14-21; PMID:10387937; http://dx.doi.org/10.1056/NEJM199907013410103
   PubMed Web of Science ®Google Scholar
• Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, Sirvent A, Champlin RE, Chao N, Gee AP, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol 2010; 11:653-60; PMID:20558104; http://dx.doi.org/10.1016/S1470-2045(10)70127-3
   PubMed Web of Science ®Google Scholar
• Parody R, Martino R, Rovira M, Vazquez L, Vazquez MJ, de la Camara R, Blazquez C, Fernandez-Aviles F, Carreras E, Salavert M, et al. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. Biol Blood Marrow Transplant 2006; 12:734-48; PMID:16785063; http://dx.doi.org/10.1016/j.bbmt.2006.03.007
   PubMed Web of Science ®Google Scholar
• Sauter C, Abboud M, Jia X, Heller G, Gonzales AM, Lubin M, Hawke R, Perales MA, van den Brink MR, Giralt S, et al. Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin. Biol Blood Marrow Transplant 2011; 17:1460-71; PMID:21310254; http://dx.doi.org/10.1016/j.bbmt.2011.02.001
   PubMed Web of Science ®Google Scholar
• Winston DJ, Gale RP, Meyer DV, Young LS. Infectious complications of human bone marrow transplantation. Med (Baltimore) 1979; 58:1-31; PMID:368507; http://dx.doi.org/10.1097/00005792-197901000-00001
   PubMed Web of Science ®Google Scholar
• Atkinson K, Storb R, Prentice RL, Weiden PL, Witherspoon RP, Sullivan K, Noel D, Thomas ED. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979; 53:720-31; PMID:34408
   PubMed Web of Science ®Google Scholar
• Meyers JD. Fungal infections in bone marrow transplant patients. Semin Oncol 1990; 17:10-3; PMID:2353204
   PubMed Web of Science ®Google Scholar
• Peterson PK, McGlave P, Ramsay NK, Rhame F, Cohen E, Perry GS, 3rd, Goldman AI, Kersey J. A prospective study of infectious diseases following bone marrow transplantation: emergence of Aspergillus and Cytomegalovirus as the major causes of mortality. Infect Control 1983; 4:81-9; PMID:6302027
   PubMedGoogle Scholar
• Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J, Andes DR, Baddley JW, Brown JM, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 2010; 50:1091-100; PMID:20218877; http://dx.doi.org/10.1086/651263
   PubMed Web of Science ®Google Scholar
• Han CS, Miller W, Haake R, Weisdorf D. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplant 1994; 13:277-83; PMID:8199570
   PubMed Web of Science ®Google Scholar
• Atkinson K, Farewell V, Storb R, Tsoi MS, Sullivan KM, Witherspoon RP, Fefer A, Clift R, Goodell B, Thomas ED. Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood 1982; 60:714-20; PMID:6213276
   PubMed Web of Science ®Google Scholar
• Velardi A, Cucciaioni S, Terenzi A, Quinti I, Aversa F, Grossi CE, Grignani F, Martelli MF. Acquisition of Ig isotype diversity after bone marrow transplantation in adults. A recapitulation of normal B cell ontogeny. J Immunol 1988; 141:815-20; PMID:3294290
   PubMed Web of Science ®Google Scholar
• Maury S, Mary JY, Rabian C, Schwarzinger M, Toubert A, Scieux C, Carmagnat M, Esperou H, Ribaud P, Devergie A, et al. Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Haematol 2001; 115:630-41; PMID:11736948; http://dx.doi.org/10.1046/j.1365-2141.2001.03135.x
   PubMed Web of Science ®Google Scholar
• Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100:4358-66; PMID:12393425; http://dx.doi.org/10.1182/blood-2002-05-1496
   PubMed Web of Science ®Google Scholar
• Mikulska M, Raiola AM, Bruno B, Furfaro E, Van Lint MT, Bregante S, Ibatici A, Del Bono V, Bacigalupo A, Viscoli C. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients. Bone Marrow Transplant 2009; 44:361-70; PMID:19308042; http://dx.doi.org/10.1038/bmt.2009.39
   PubMed Web of Science ®Google Scholar
• Barker JN, Hough RE, van Burik JA, DeFor TE, MacMillan ML, O'Brien MR, Wagner JE. Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. Biol Blood Marrow Transplant 2005; 11:362-70; PMID:15846290; http://dx.doi.org/10.1016/j.bbmt.2005.02.004
   PubMed Web of Science ®Google Scholar
• Brunstein CG, Weisdorf DJ, DeFor T, Barker JN, Tolar J, van Burik JA, Wagner JE. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006; 108:2874-80; PMID:16804113; http://dx.doi.org/10.1182/blood-2006-03-011791
   PubMed Web of Science ®Google Scholar
• Cohen J, Gandhi M, Naik P, Cubitt D, Rao K, Thaker U, Davies EG, Gaspar HB, Amrolia PJ, Veys P. Increased incidence of EBV-related disease following paediatric stem cell transplantation with reduced-intensity conditioning. Br J Haematol 2005; 129:229-39; PMID:15813851; http://dx.doi.org/10.1111/j.1365-2141.2005.05439.x
   PubMed Web of Science ®Google Scholar
• Storek J, Geddes M, Khan F, Huard B, Helg C, Chalandon Y, Passweg J, Roosnek E. Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Semin Immunopathol 2008; 30:425-37.; PMID:18949477; http://dx.doi.org/10.1007/s00281-008-0132-5
   PubMed Web of Science ®Google Scholar
• Bosch M, Khan FM, Storek J. Immune reconstitution after hematopoietic cell transplantation. Curr Opin Hematol 2012; 19:324-35.; PMID:22517587; http://dx.doi.org/10.1097/MOH.0b013e328353bc7d
   PubMed Web of Science ®Google Scholar
• Rapoport AP, Miller Watelet LF, Linder T, Eberly S, Raubertas RF, Lipp J, Duerst R, Abboud CN, Constine L, Andrews J, et al. Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants. J Clin Oncol 1999; 17:2446-53; PMID:10561308
   PubMed Web of Science ®Google Scholar
• Stiff P. Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant 2001; 27 Suppl 2:S3-S11; http://dx.doi.org/10.1038/sj.bmt.1702863
   PubMed Web of Science ®Google Scholar
• Ruescher TJ, Sodeifi A, Scrivani SJ, Kaban LB, Sonis ST. The impact of mucositis on α-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 1998; 82:2275-81; PMID:9610710; http://dx.doi.org/10.1002/(SICI)1097-0142(19980601)82:11%3c2275::AID-CNCR25%3e3.0.CO;2-Q
   PubMed Web of Science ®Google Scholar
• Donnelly JP, Muus P, Horrevorts AM, Sauerwein RW, De Pauw BE. Failure of clindamycin to influence the course of severe oromucositis associated with streptococcal bacteraemia in allogeneic bone marrow transplant recipients. Scand J Infect Dis 1993; 25:43-50; PMID:8460348; http://dx.doi.org/10.1080/00365549309169668
   PubMed Web of Science ®Google Scholar
• Epstein JB, Hancock PJ, Nantel S. Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 96:154-63; PMID:12931087; http://dx.doi.org/10.1016/S1079-2104(03)00296-8
   PubMed Web of Science ®Google Scholar
• Eisen D, Essell J, Broun ER. Oral cavity complications of bone marrow transplantation. Semin Cutan Med Surg 1997; 16:265-72; PMID:9421217; http://dx.doi.org/10.1016/S1085-5629(97)80015-6
   PubMed Web of Science ®Google Scholar
• Wingard JR. Fungal infections after bone marrow transplant. Biol Blood Marrow Transplant 1999; 5:55-68; PMID:10371357; http://dx.doi.org/10.1053/bbmt.1999.v5.pm10371357
   PubMedGoogle Scholar
• Epstein JB, Ransier A, Lunn R, Chin E, Jacobson JJ, Le N, Reece D. Prophylaxis of candidiasis in patients with leukemia and bone marrow transplants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 81:291-6; PMID:8653462; http://dx.doi.org/10.1016/S1079-2104(96)80328-3
   PubMed Web of Science ®Google Scholar
• Avigan D, Richardson P, Elias A, Demetri G, Shapiro M, Schnipper L, Wheeler C. Neutropenic enterocolitis as a complication of high dose chemotherapy with stem cell rescue in patients with solid tumors: a case series with a review of the literature. Cancer 1998; 83:409-14; PMID:9690531; http://dx.doi.org/10.1002/(SICI)1097-0142(19980801)83:3%3c409::AID-CNCR7%3e3.0.CO;2-J
   PubMed Web of Science ®Google Scholar
• Ettinghausen SE. Collagenous colitis, eosinophilic colitis, and neutropenic colitis. Surg Clin North Am 1993; 73:993-1016; PMID:8378836
   PubMed Web of Science ®Google Scholar
• Taur Y, Jenq RR, Perales MA, Littmann ER, Morjaria S, Ling L, No D, Gobourne A, Viale A, Dahi PB, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood 2014; 124:1174-82; PMID:24939656; http://dx.doi.org/10.1182/blood-2014-02-554725
   PubMed Web of Science ®Google Scholar
• Jenq RR, Ubeda C, Taur Y, Menezes CC, Khanin R, Dudakov JA, Liu C, West ML, Singer NV, Equinda MJ, et al. Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation. J Exp Med 2012; 209:903-11; PMID:22547653; http://dx.doi.org/10.1084/jem.20112408
   PubMed Web of Science ®Google Scholar
• Sarrabayrouse G, Bossard C, Chauvin JM, Jarry A, Meurette G, Quevrain E, Bridonneau C, Preisser L, Asehnoune K, Labarriere N, et al. CD4CD8alphaalpha lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease. PLoS Biol 2014; 12:e1001833; PMID:24714093; http://dx.doi.org/10.1371/journal.pbio.1001833
   PubMedGoogle Scholar
• Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, Fukuda S, Saito T, Narushima S, Hase K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013; 500:232-6; PMID:23842501; http://dx.doi.org/10.1038/nature12331
   PubMed Web of Science ®Google Scholar
• Mathewson ND, Jenq R, Mathew AV, Koenigsknecht M, Hanash A, Toubai T, Oravecz-Wilson K, Wu SR, Sun Y, Rossi C, et al. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol 2016; 17:505-13; PMID:26998764; http://dx.doi.org/10.1038/ni.3400
   PubMed Web of Science ®Google Scholar
• Rossi S, Blazar BR, Farrell CL, Danilenko DM, Lacey DL, Weinberg KI, Krenger W, Hollander GA. Keratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host disease. Blood 2002; 100:682-91; PMID:12091365; http://dx.doi.org/10.1182/blood.V100.2.682
   PubMed Web of Science ®Google Scholar
• Min D, Panoskaltsis-Mortari A, Kuro OM, Hollander GA, Blazar BR, Weinberg KI. Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging. Blood 2007; 109:2529-37; PMID:17138819; http://dx.doi.org/10.1182/blood-2006-08-043794
   PubMed Web of Science ®Google Scholar
• Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T, Shea T, Yanovich S, Hansen K, Noga S, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004; 351:2590-8; PMID:15602019; http://dx.doi.org/10.1056/NEJMoa040125
   PubMed Web of Science ®Google Scholar
• Milone G, Leotta S, Cupri A, Fauci AL, Spina P, Parisi M, Berritta D, Tripepi G. Palifermin reduces infection rate and hyperfibrinogenemia in patients treated with high-dose chemotherapy based on beam or BU-thiothepa. Bone Marrow Transplant 2014; 49:1193-7; PMID:25000456; http://dx.doi.org/10.1038/bmt.2014.140
   PubMed Web of Science ®Google Scholar
• Sayles C, Hickerson SC, Bhat RR, Hall J, Garey KW, Trivedi MV. Oral glutamine in preventing Treatment-Related Mucositis in adult patients with cancer: a systematic review. Nutr Clin Pract 2016 Apr;31(2):171-9; PMID:26507188; http://dx.doi.org/10.1177/0884533615611857
   PubMed Web of Science ®Google Scholar
• Worthington HV, Clarkson JE, Bryan G, Furness S, Glenny AM, Littlewood A, McCabe MG, Meyer S, Khalid T. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 2011; 25(6):284-5:CD000978
   Google Scholar
• Lieschke GJ, Ramenghi U, O'Connor MP, Sheridan W, Szer J, Morstyn G. Studies of oral neutrophil levels in patients receiving G-CSF after autologous marrow transplantation. Br J Haematol 1992; 82:589-95; PMID:1283080; http://dx.doi.org/10.1111/j.1365-2141.1992.tb06472.x
   PubMed Web of Science ®Google Scholar
• Cheretakis C, Dror Y, Glogauer M. A noninvasive oral rinse assay to monitor engraftment, neutrophil tissue delivery and susceptibility to infection following HSCT in pediatric patients. Bone Marrow Transplant 2005; 36:227-32; PMID:15937506
   PubMed Web of Science ®Google Scholar
• Cheretakis C, Leung R, Sun CX, Dror Y, Glogauer M. Timing of neutrophil tissue repopulation predicts restoration of innate immune protection in a murine bone marrow transplantation model. Blood 2006; 108:2821-6; PMID:16804110; http://dx.doi.org/10.1182/blood-2006-04-018184
   PubMed Web of Science ®Google Scholar
• Wiltschke C, Krainer M, Nanut M, Wagner A, Linkesch W, Zielinski CC. In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activity. J Interferon Cytokine Res 1995; 15:249-53; PMID:7584671; http://dx.doi.org/10.1089/jir.1995.15.249
   PubMed Web of Science ®Google Scholar
• Fabian I, Kletter Y, Bleiberg I, Gadish M, Naparsteck E, Slavin S. Effect of exogenous recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor on neutrophil function following allogeneic bone marrow transplantation. Exp Hematol 1991; 19:868-73; PMID:1716591
   PubMed Web of Science ®Google Scholar
• Gadish M, Kletter Y, Flidel O, Nagler A, Slavin S, Fabian I. Effects of recombinant human granulocyte and granulocyte-macrophage colony-stimulating factors on neutrophil function following autologous bone marrow transplantation. Leuk Res 1991; 15:1175-82; PMID:1722549; http://dx.doi.org/10.1016/0145-2126(91)90187-X
   PubMed Web of Science ®Google Scholar
• Ruef C, Coleman DL. Granulocyte-macrophage colony-stimulating factor: pleiotropic cytokine with potential clinical usefulness. Rev Infect Dis 1990; 12:41-62; PMID:2405468; http://dx.doi.org/10.1093/clinids/12.1.41
   PubMedGoogle Scholar
• Wan L, Zhang Y, Lai Y, Jiang M, Song Y, Zhou J, Zhang Z, Duan X, Fu Y, Liao L, et al. Effect of Granulocyte-Macrophage Colony-Stimulating factor on prevention and treatment of invasive fungal disease in recipients of allogeneic stem-cell transplantation: A prospective multicenter randomized phase IV Trial. J Clin Oncol 2015; 33:3999-4006; PMID:26392095; http://dx.doi.org/10.1200/JCO.2014.60.5121
   PubMed Web of Science ®Google Scholar
• Zimmerli W, Zarth A, Gratwohl A, Speck B. Neutrophil function and pyogenic infections in bone marrow transplant recipients. Blood 1991; 77:393-9; PMID:1845932
   PubMed Web of Science ®Google Scholar
• Cayeux S, Meuer S, Pezzutto A, Korbling M, Haas R, Schulz R, Dorken B. Allogeneic mixed lymphocyte reactions during a second round of ontogeny: normal accessory cells did not restore defective interleukin-2 (IL-2) synthesis in T cells but induced responsiveness to exogeneous IL-2. Blood 1989; 74:2278-84; PMID:2478226
   PubMed Web of Science ®Google Scholar
• Sahdev I, O'Reilly R, Black P, Heller G, Hoffmann M. Interleukin-1 production following T-cell-depleted and unmodified marrow grafts. Pediatr Hematol Oncol 1996; 13:55-67; PMID:8718503; http://dx.doi.org/10.3109/08880019609033372
   PubMed Web of Science ®Google Scholar
• Clark RA, Johnson FL, Klebanoff SJ, Thomas ED. Defective neutrophil chemotaxis in bone marrow transplant patients. J Clin Invest 1976; 58:22-31; PMID:777029; http://dx.doi.org/10.1172/JCI108452
   PubMed Web of Science ®Google Scholar
• Stuehler C, Kuenzli E, Jaeger VK, Baettig V, Ferracin F, Rajacic Z, Kaiser D, Bernardini C, Forrer P, Weisser M, et al. Immune reconstitution after allogeneic hematopoietic stem cell transplantation and association with occurrence and outcome of invasive aspergillosis. J Infect Dis 2015; 212:959-67; PMID:25748323; http://dx.doi.org/10.1093/infdis/jiv143
   PubMed Web of Science ®Google Scholar
• Bourgeois C, Majer O, Frohner IE, Tierney L, Kuchler K. Fungal attacks on mammalian hosts: pathogen elimination requires sensing and tasting. Curr Opin Microbiol 2010; 13:401-8; PMID:20538507; http://dx.doi.org/10.1016/j.mib.2010.05.004
   PubMed Web of Science ®Google Scholar
• Jouault T, Sarazin A, Martinez-Esparza M, Fradin C, Sendid B, Poulain D. Host responses to a versatile commensal: PAMPs and PRRs interplay leading to tolerance or infection by Candida albicans. Cell Microbiol 2009; 11:1007-15; PMID:19388906; http://dx.doi.org/10.1111/j.1462-5822.2009.01318.x
   PubMed Web of Science ®Google Scholar
• Moretti S, Bellocchio S, Bonifazi P, Bozza S, Zelante T, Bistoni F, Romani L. The contribution of PARs to inflammation and immunity to fungi. Mucosal Immunol 2008; 1:156-68; PMID:19079173; http://dx.doi.org/10.1038/mi.2007.13
   PubMed Web of Science ®Google Scholar
• Gross O, Gewies A, Finger K, Schafer M, Sparwasser T, Peschel C, Forster I, Ruland J. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 2006; 442:651-6; PMID:16862125; http://dx.doi.org/10.1038/nature04926
   PubMed Web of Science ®Google Scholar
• Brown GD. Innate antifungal immunity: the key role of phagocytes. Annu Rev Immunol 2011; 29:1-21; PMID:20936972; http://dx.doi.org/10.1146/annurev-immunol-030409-101229
   PubMed Web of Science ®Google Scholar
• Romani L. Immunity to fungal infections. Nat Rev Immunol 2011; 11:275-88; PMID:21394104; http://dx.doi.org/10.1038/nri2939
   PubMed Web of Science ®Google Scholar
• Robertson MJ, Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990; 76:2421-38; PMID:2265240
   PubMed Web of Science ®Google Scholar
• Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22:633-40; PMID:11698225; http://dx.doi.org/10.1016/S1471-4906(01)02060-9
   PubMed Web of Science ®Google Scholar
• Fehniger TA, Cooper MA, Nuovo GJ, Cella M, Facchetti F, Colonna M, Caligiuri MA. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 2003; 101:3052-7; PMID:12480696; http://dx.doi.org/10.1182/blood-2002-09-2876
   PubMed Web of Science ®Google Scholar
• Small TN, Papadopoulos EB, Boulad F, Black P, Castro-Malaspina H, Childs BH, Collins N, Gillio A, George D, Jakubowski A, et al. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood 1999; 93:467-80; PMID:9885208
   PubMed Web of Science ®Google Scholar
• Thomson BG, Robertson KA, Gowan D, Heilman D, Broxmeyer HE, Emanuel D, Kotylo P, Brahmi Z, Smith FO. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood 2000; 96:2703-11; PMID:11023501
   PubMed Web of Science ®Google Scholar
• Ruggeri A, Peffault de Latour R, Carmagnat M, Clave E, Douay C, Larghero J, Cayuela JM, Traineau R, Robin M, Madureira A, et al. Outcomes, infections, and immune reconstitution after double cord blood transplantation in patients with high-risk hematological diseases. Transpl Infect Dis 2011; 13:456-65; PMID:21466640; http://dx.doi.org/10.1111/j.1399-3062.2011.00632.x
   PubMed Web of Science ®Google Scholar
• Jacobson CA, Turki AT, McDonough SM, Stevenson KE, Kim HT, Kao G, Herrera MI, Reynolds CG, Alyea EP, Ho VT, et al. Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2012; 18:565-74; PMID:21875503; http://dx.doi.org/10.1016/j.bbmt.2011.08.018
   PubMed Web of Science ®Google Scholar
• Somers JA, Brand A, van Hensbergen Y, Mulder A, Oudshoorn M, Sintnicolaas K, Gratama JW, Falkenburg JH, Braakman E, Cornelissen JJ. Double umbilical cord blood transplantation: a study of early engraftment kinetics in leukocyte subsets using HLA-specific monoclonal antibodies. Biol Blood Marrow Transplant 2013; 19:266-73; PMID:23041604; http://dx.doi.org/10.1016/j.bbmt.2012.09.022
   PubMed Web of Science ®Google Scholar
• Saliba RM, Rezvani K, Leen A, Jorgensen J, Shah N, Hosing C, Parmar S, Oran B, Olson A, Rondon G, et al. General and virus-specific immune cell reconstitution after double cord blood transplantation. Biol Blood Marrow Transplant 2015; 21(7):1284-90; PMID:25708219; http://dx.doi.org/10.1016/j.bbmt.2015.02.017
   PubMed Web of Science ®Google Scholar
• Brahmi Z, Hommel-Berrey G, Smith F, Thomson B. NK cells recover early and mediate cytotoxicity via perforin/granzyme and Fas/FasL pathways in umbilical cord blood recipients. Hum Immunol 2001; 62:782-90; PMID:11476901; http://dx.doi.org/10.1016/S0198-8859(01)00275-0
   PubMed Web of Science ®Google Scholar
• Hercend T, Takvorian T, Nowill A, Tantravahi R, Moingeon P, Anderson KC, Murray C, Bohuon C, Ythier A, Ritz J. Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation. Blood 1986; 67:722-8; PMID:3081066
   PubMed Web of Science ®Google Scholar
• Hokland M, Jacobsen N, Ellegaard J, Hokland P. Natural killer function following allogeneic bone marrow transplantation. Very early reemergence but strong dependence of cytomegalovirus infection. Transplantation 1988; 45:1080-4; PMID:2837847; http://dx.doi.org/10.1097/00007890-198806000-00016
   PubMed Web of Science ®Google Scholar
• Saliba RM, Rezvani K, Leen A, Jorgensen J, Shah N, Hosing C, Parmar S, Oran B, Olson A, Rondon G, et al. General and virus-specific immune cell reconstitution after double cord blood transplantation. Biol Blood Marrow Transplant 2015; 21:1284-90; PMID:25708219; http://dx.doi.org/10.1016/j.bbmt.2015.02.017
   PubMed Web of Science ®Google Scholar
• Petersen SL, Ryder LP, Bjork P, Madsen HO, Heilmann C, Jacobsen N, Sengelov H, Vindelov LL. A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors. Bone Marrow Transplant 2003; 32:65-72; PMID:12815480; http://dx.doi.org/10.1038/sj.bmt.1704084
   PubMed Web of Science ®Google Scholar
• Horowitz A, Stegmann KA, Riley EM. Activation of natural killer cells during microbial infections. Front Immunol 2011; 2:88; PMID:22566877
   PubMed Web of Science ®Google Scholar
• Adib-Conquy M, Scott-Algara D, Cavaillon JM, Souza-Fonseca-Guimaraes F. TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals. Immunol Cell Biol 2014; 92:256-62; PMID:24366517; http://dx.doi.org/10.1038/icb.2013.99
   PubMed Web of Science ®Google Scholar
• Lunemann S, Malone DF, Hengst J, Port K, Grabowski J, Deterding K, Markova A, Bremer B, Schlaphoff V, Cornberg M, et al. Compromised function of natural killer cells in acute and chronic viral hepatitis. J Infect Dis 2014; 209:1362-73; PMID:24154737; http://dx.doi.org/10.1093/infdis/jit561
   PubMed Web of Science ®Google Scholar
• Hall LJ, Murphy CT, Hurley G, Quinlan A, Shanahan F, Nally K, Melgar S. Natural killer cells protect against mucosal and systemic infection with the enteric pathogen Citrobacter rodentium. Infect Immun 2013; 81:460-9; PMID:23208605; http://dx.doi.org/10.1128/IAI.00953-12
   PubMed Web of Science ®Google Scholar
• Han X, Fan Y, Wang S, Jiao L, Qiu H, Yang X. NK cells contribute to intracellular bacterial infection-mediated inhibition of allergic responses. J Immunol 2008; 180:4621-8; PMID:18354185; http://dx.doi.org/10.4049/jimmunol.180.7.4621
   PubMed Web of Science ®Google Scholar
• Nogusa S, Ritz BW, Kassim SH, Jennings SR, Gardner EM. Characterization of age-related changes in natural killer cells during primary influenza infection in mice. Mech Ageing Dev 2008; 129:223-30; PMID:18304606; http://dx.doi.org/10.1016/j.mad.2008.01.003
   PubMed Web of Science ®Google Scholar
• Alter G, Martin MP, Teigen N, Carr WH, Suscovich TJ, Schneidewind A, Streeck H, Waring M, Meier A, Brander C, et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 2007; 204:3027-36; PMID:18025129; http://dx.doi.org/10.1084/jem.20070695
   PubMed Web of Science ®Google Scholar
• Harshan KV, Gangadharam PR. In vivo depletion of natural killer cell activity leads to enhanced multiplication of Mycobacterium avium complex in mice. Infect Immun 1991; 59:2818-21; PMID:1855997
   PubMed Web of Science ®Google Scholar
• Katz P, Yeager H, Jr, Whalen G, Evans M, Swartz RP, Roecklein J. Natural killer cell-mediated lysis of Mycobacterium-avium complex-infected monocytes. J Clin Immunol 1990; 10:71-7; PMID:2312668; http://dx.doi.org/10.1007/BF00917500
   PubMed Web of Science ®Google Scholar
• Blanchard DK, Stewart WE, 2nd, Klein TW, Friedman H, Djeu JY. Cytolytic activity of human peripheral blood leukocytes against Legionella pneumophila-infected monocytes: characterization of the effector cell and augmentation by interleukin 2. J Immunol 1987; 139:551-6; PMID:3496384
   PubMed Web of Science ®Google Scholar
• Klimpel GR, Niesel DW, Klimpel KD. Natural cytotoxic effector cell activity against Shigella flexneri-infected HeLa cells. J Immunol 1986; 136:1081-6; PMID:3510252
   PubMed Web of Science ®Google Scholar
• Bouzani M, Ok M, McCormick A, Ebel F, Kurzai O, Morton CO, Einsele H, Loeffler J. Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFN-gamma release. J Immunol 2011; 187:1369-76; PMID:21697457; http://dx.doi.org/10.4049/jimmunol.1003593
   PubMed Web of Science ®Google Scholar
• Schmidt S, Tramsen L, Hanisch M, Latge JP, Huenecke S, Koehl U, Lehrnbecher T. Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia. J Infect Dis 2011; 203:430-5; PMID:21208932; http://dx.doi.org/10.1093/infdis/jiq062
   PubMed Web of Science ®Google Scholar
• Orange JS. Human natural killer cell deficiencies. Curr Opin Allergy Clin Immunol 2006; 6:399-409; PMID:17088643; http://dx.doi.org/10.1097/ACI.0b013e3280106b65
   PubMed Web of Science ®Google Scholar
• Storek J, Dawson MA, Storer B, Stevens-Ayers T, Maloney DG, Marr KA, Witherspoon RP, Bensinger W, Flowers ME, Martin P, et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001; 97:3380-9; PMID:11369627; http://dx.doi.org/10.1182/blood.V97.11.3380
   PubMed Web of Science ®Google Scholar
• Alho AC, Kim HT, Chammas MJ, Reynolds CG, Matos TR, Forcade E, Whangbo J, Nikiforow S, Cutler CS, Koreth J, et al. Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD. Blood 2016 Feb 4;127(5):646-57; PMID:26670634; http://dx.doi.org/1182/blood-2015-10-672345
   PubMed Web of Science ®Google Scholar
• Vitale C, Pitto A, Benvenuto F, Ponte M, Bellomo R, Frassoni F, Mingari MC, Bacigalupo A, Moretta L. Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors. Hematol J 2000; 1:136-44; PMID:11920181; http://dx.doi.org/10.1038/sj.thj.6200018
   PubMedGoogle Scholar
• Dokhelar MC, Wiels J, Lipinski M, Tetaud C, Devergie A, Gluckman E, Tursz T. Natural killer cell activity in human bone marrow recipients: early reappearance of peripheral natural killer activity in graft-versus-host disease. Transplantation 1981; 31:61-5; PMID:7015602; http://dx.doi.org/10.1097/00007890-198101000-00014
   PubMed Web of Science ®Google Scholar
• Della Chiesa M, Falco M, Bertaina A, Muccio L, Alicata C, Frassoni F, Locatelli F, Moretta L, Moretta A. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C−/− umbilical cord blood. J Immunol 2014; 192:1471-9; PMID:24442432; http://dx.doi.org/10.4049/jimmunol.1302053
   PubMed Web of Science ®Google Scholar
• Jonjic S, Babic M, Polic B, Krmpotic A. Immune evasion of natural killer cells by viruses. Curr Opin Immunol 2008; 20:30-8; PMID:18206359; http://dx.doi.org/10.1016/j.coi.2007.11.002
   PubMed Web of Science ®Google Scholar
• Kurosaki T, Kometani K, Ise W. Memory B cells. Nat Rev Immunol 2015; 15:149-59; PMID:25677494; http://dx.doi.org/10.1038/nri3802
   PubMed Web of Science ®Google Scholar
• Batista FD, Harwood NE. The who, how and where of antigen presentation to B cells. Nat Rev Immunol 2009; 9:15-27; PMID:19079135; http://dx.doi.org/10.1038/nri2454
   PubMed Web of Science ®Google Scholar
• Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood 2005; 105:4390-8; PMID:15701725; http://dx.doi.org/10.1182/blood-2004-11-4284
   PubMed Web of Science ®Google Scholar
• Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998; 188:1679-89; PMID:9802980; http://dx.doi.org/10.1084/jem.188.9.1679
   PubMed Web of Science ®Google Scholar
• Storek J, Ferrara S, Ku N, Giorgi JV, Champlin RE, Saxon A. B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny? Bone Marrow Transplant 1993; 12:387-98; PMID:8275039
   PubMed Web of Science ®Google Scholar
• Small TN, Keever CA, Weiner-Fedus S, Heller G, O'Reilly RJ, Flomenberg N. B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. Blood 1990; 76:1647-56; PMID:1698484
   PubMed Web of Science ®Google Scholar
• Burns DM, Tierney R, Shannon-Lowe C, Croudace J, Inman C, Abbotts B, Nagra S, Fox CP, Chaganti S, Craddock CF, et al. Memory B cell reconstitution following allogeneic haematopoietic stem cell transplantation is an EBV-associated transformation event. Blood 2015; 126(25):2665-75; PMID:26450987; http://dx.doi.org/10.1182/blood-2015-08-665000
   PubMed Web of Science ®Google Scholar
• Marie-Cardine A, Divay F, Dutot I, Green A, Perdrix A, Boyer O, Contentin N, Tilly H, Tron F, Vannier JP, et al. Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clin Immunol 2008; 127:14-25; PMID:18191619; http://dx.doi.org/10.1016/j.clim.2007.11.013
   PubMed Web of Science ®Google Scholar
• Ottinger HD, Beelen DW, Scheulen B, Schaefer UW, Grosse-Wilde H. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 1996; 88:2775-9; PMID:8839875
   PubMed Web of Science ®Google Scholar
• Gale RP, Opelz G, Mickey MR, Graze PR, Saxon A. Immunodeficiency following allogeneic bone marrow transplantation. Transplant Proc 1978; 10:223-7; PMID:147534
   PubMed Web of Science ®Google Scholar
• Elfenbein GJ, Anderson PN, Humphrey RL, Mullins GM, Sensenbrenner LL, Wands JR, Santos GW. Immune system reconstitution following allogeneic bone marrow transplantation in man: a multiparameter analysis. Transplant Proc 1976; 8:641-6; PMID:136774
   PubMed Web of Science ®Google Scholar
• Storb R, Ochs HD, Weiden PL, Thomas ED. Immunologic reactivity in marrow graft recipients. Transplant Proc 1976; 8:637-9; PMID:793117
   PubMed Web of Science ®Google Scholar
• Noel DR, Witherspoon RP, Storb R, Atkinson K, Doney K, Mickelson EM, Ochs HD, Warren RP, Weiden PL, Thomas ED. Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors. Blood 1978; 51:1087-105; PMID:25684
   PubMed Web of Science ®Google Scholar
• Linch DC, Knott LJ, Thomas RM, Harper P, Goldstone AH, Davis EG, Levinski RJ. T cell regeneration after allogeneic and autologous bone marrow transplantation. Br J Haematol 1983; 53:451-8; PMID:6218816; http://dx.doi.org/10.1111/j.1365-2141.1983.tb02046.x
   PubMed Web of Science ®Google Scholar
• Ueda M, Harada M, Shiobara S, Nakao S, Kondo K, Odaka K, Matsue K, Mori T, Hattori K. T lymphocyte reconstitution in long-term survivors after allogeneic and autologous marrow transplantation. Transplantation 1984; 37:552-6; PMID:6427996; http://dx.doi.org/10.1097/00007890-198406000-00005
   PubMed Web of Science ®Google Scholar
• Lum LG. The kinetics of immune reconstitution after human marrow transplantation. Blood 1987; 69:369-80; PMID:3542077
   PubMed Web of Science ®Google Scholar
• Storek J, Saxon A. Reconstitution of B cell immunity following bone marrow transplantation. Bone Marrow Transplant 1992; 9:395-408; PMID:1628122
   PubMed Web of Science ®Google Scholar
• Gerritsen EJ, van Tol MJ, Lankester AC, van der Weijden-Ragas CP, Jol-van der Zijde CM, Oudeman-Gruber NJ, Radl J, Vossen JM. Immunoglobulin levels and monoclonal gammopathies in children after bone marrow transplantation. Blood 1993; 82:3493-502; PMID:8241517
   PubMed Web of Science ®Google Scholar
• Matsue K, Lum LG, Witherspoon RP, Storb R. Proliferative and differentiative responses of B cells from human marrow graft recipients to T cell-derived factors. Blood 1987; 69:308-15; PMID:3539229
   PubMed Web of Science ®Google Scholar
• Perreault C, Giasson M, Gyger M, Belanger R, David M, Bonny Y, Boileau J, Barcelo R, Moquin JP. Serum immunoglobulin levels following allogeneic bone marrow transplantation. Blut 1985; 51:137-42; PMID:3896351; http://dx.doi.org/10.1007/BF00320027
   PubMedGoogle Scholar
• Norhagen G, Engstrom PE, Bjorkstrand B, Hammarstrom L, Smith CI, Ringden O. Salivary and serum immunoglobulins in recipients of transplanted allogeneic and autologous bone marrow. Bone Marrow Transplant 1994; 14:229-34; PMID:7994237
   PubMed Web of Science ®Google Scholar
• Aucouturier P, Barra A, Intrator L, Cordonnier C, Schulz D, Duarte F, Vernant JP, Preud'homme JL. Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. Blood 1987; 70:779-85; PMID:3304461
   PubMed Web of Science ®Google Scholar
• Umetsu DT, Ambrosino DM, Quinti I, Siber GR, Geha RS. Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. N Engl J Med 1985; 313:1247-51; PMID:3877240; http://dx.doi.org/10.1056/NEJM198511143132002
   PubMed Web of Science ®Google Scholar
• Witherspoon RP, Storb R, Ochs HD, Fluornoy N, Kopecky KJ, Sullivan KM, Deeg JH, Sosa R, Noel DR, Atkinson K, et al. Recovery of antibody production in human allogeneic marrow graft recipients: influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment. Blood 1981; 58:360-8; PMID:6454452
   PubMed Web of Science ®Google Scholar
• Martinez C, Urbano-Ispizua A, Rozman C, Marin P, Rovira M, Sierra J, Montfort N, Carreras E, Montserrat E. Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts. Exp Hematol 1999; 27:561-8; PMID:10089920; http://dx.doi.org/10.1016/S0301-472X(98)00029-0
   PubMed Web of Science ®Google Scholar
• van Tol MJ, Gerritsen EJ, de Lange GG, van Leeuwen AM, Jol-van der Zijde CM, Oudeman-Gruber NJ, de Vries E, Radl J, Vossen JM. The origin of IgG production and homogeneous IgG components after allogeneic bone marrow transplantation. Blood 1996; 87:818-26; PMID:8555508
   PubMed Web of Science ®Google Scholar
• Parkkali T, Ruutu T, Stenvik M, Kuronen T, Kayhty H, Hovi T, Olander RM, Volin L, Ruutu P. Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation. APMIS 1996; 104:383-8; PMID:8703445; http://dx.doi.org/10.1111/j.1699-0463.1996.tb00731.x
   PubMed Web of Science ®Google Scholar
• Gandhi MK, Egner W, Sizer L, Inman I, Zambon M, Craig JI, Marcus RE. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients. Bone Marrow Transplant 2001; 28:775-81; PMID:11781630; http://dx.doi.org/10.1038/sj.bmt.1703239
   PubMed Web of Science ®Google Scholar
• Pirofski LA, Casadevall A. Use of licensed vaccines for active immunization of the immunocompromised host. Clin Microbiol Rev 1998; 11:1-26; PMID:9457426
   PubMed Web of Science ®Google Scholar
• Avigan D, Pirofski LA, Lazarus HM. Vaccination against infectious disease following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001; 7:171-83; PMID:11302551; http://dx.doi.org/10.1053/bbmt.2001.v7.pm11302551
   PubMed Web of Science ®Google Scholar
• Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014; 58:e44-100; PMID:24311479; http://dx.doi.org/10.1093/cid/cit684
   PubMed Web of Science ®Google Scholar
• CDC. Centers for Disease Control and Prevention. Vaccination of hematopoietic stem cell transplant (HSCT) recipients. 2011
   Google Scholar
• Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000; 290:92-7; PMID:11021806; http://dx.doi.org/10.1126/science.290.5489.92
   PubMed Web of Science ®Google Scholar
• Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004; 22:745-63; PMID:15032595; http://dx.doi.org/10.1146/annurev.immunol.22.012703.104702
   PubMed Web of Science ®Google Scholar
• Mackall CL, Bare CV, Granger LA, Sharrow SO, Titus JA, Gress RE. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J Immunol 1996; 156:4609-16; PMID:8648103
   PubMed Web of Science ®Google Scholar
• Mackall CL, Hakim FT, Gress RE. T-cell regeneration: all repertoires are not created equal. Immunol Today 1997; 18:245-51; PMID:9153957; http://dx.doi.org/10.1016/S0167-5699(97)81664-7
   PubMedGoogle Scholar
• Clave E, Busson M, Douay C, Peffault de Latour R, Berrou J, Rabian C, Carmagnat M, Rocha V, Charron D, Socie G, et al. Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation. Blood 2009; 113:6477-84; PMID:19258596; http://dx.doi.org/10.1182/blood-2008-09-176594
   PubMed Web of Science ®Google Scholar
• Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Magrath IT, Wexler LH, Dimitrov DS, Gress RE. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 1997; 89:3700-7; PMID:9160675
   PubMed Web of Science ®Google Scholar
• Mackall CL, Granger L, Sheard MA, Cepeda R, Gress RE. T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood 1993; 82:2585-94; PMID:7691265
   PubMed Web of Science ®Google Scholar
• Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Horowitz ME, Magrath IT, Shad AT, Steinberg SM, et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332:143-9; PMID:7800006; http://dx.doi.org/10.1056/NEJM199501193320303
   PubMed Web of Science ®Google Scholar
• Fallen PR, Duarte RF, McGreavey L, Potter M, Ethell M, Prentice HG, Madrigal JA, Travers PJ. Identification of non-naive CD4+CD45RA+ T cell subsets in adult allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplant 2003; 32:609-16; PMID:12953134; http://dx.doi.org/10.1038/sj.bmt.1704185
   PubMed Web of Science ®Google Scholar
• Forman SJ, Nocker P, Gallagher M, Zaia J, Wright C, Bolen J, Mills B, Hecht T. Pattern of T cell reconstitution following allogeneic bone marrow transplantation for acute hematological malignancy. Transplantation 1982; 34:96-8; PMID:6753269; http://dx.doi.org/10.1097/00007890-198208000-00007
   PubMed Web of Science ®Google Scholar
• Storek J, Witherspoon RP, Maloney DG, Chauncey TR, Storb R. Improved reconstitution of CD4 T cells and B cells but worsened reconstitution of serum IgG levels after allogeneic transplantation of blood stem cells instead of marrow. Blood 1997; 89:3891-3; PMID:9160701
   PubMed Web of Science ®Google Scholar
• Garderet L, Dulphy N, Douay C, Chalumeau N, Schaeffer V, Zilber MT, Lim A, Even J, Mooney N, Gelin C, et al. The umbilical cord blood alphabeta T-cell repertoire: characteristics of a polyclonal and naive but completely formed repertoire. Blood 1998; 91:340-6; PMID:9414303
   PubMed Web of Science ®Google Scholar
• Moretta A, Maccario R, Fagioli F, Giraldi E, Busca A, Montagna D, Miniero R, Comoli P, Giorgiani G, Zecca M, et al. Analysis of immune reconstitution in children undergoing cord blood transplantation. Exp Hematol 2001; 29:371-9; PMID:11274766; http://dx.doi.org/10.1016/S0301-472X(00)00667-6
   PubMed Web of Science ®Google Scholar
• Luznik L, Fuchs EJ. High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation. Immunol Res 2010; 47:65-77; PMID:20066512; http://dx.doi.org/10.1007/s12026-009-8139-0
   PubMed Web of Science ®Google Scholar
• Roberto A, Castagna L, Zanon V, Bramanti S, Crocchiolo R, McLaren JE, Gandolfi S, Tentorio P, Sarina B, Timofeeva I, et al. Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation. Blood 2015; 125:2855-64; PMID:25742699; http://dx.doi.org/10.1182/blood-2014-11-608406
   PubMed Web of Science ®Google Scholar
• Cieri N, Oliveira G, Greco R, Forcato M, Taccioli C, Cianciotti B, Valtolina V, Noviello M, Vago L, Bondanza A, et al. Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation. Blood 2015; 125:2865-74; PMID:25736310; http://dx.doi.org/10.1182/blood-2014-11-608539
   PubMed Web of Science ®Google Scholar
• Kneba M, Bolz I, Linke B, Bertram J, Rothaupt D, Hiddemann W. Characterization of clone-specific rearrangement T-cell receptor gamma-chain genes in lymphomas and leukemias by the polymerase chain reaction and DNA sequencing. Blood 1994; 84:574-81; PMID:8025283
   PubMed Web of Science ®Google Scholar
• van den Beemd R, Boor PP, van Lochem EG, Hop WC, Langerak AW, Wolvers-Tettero IL, Hooijkaas H, van Dongen JJ. Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry 2000; 40:336-45; PMID:10918284; http://dx.doi.org/10.1002/1097-0320(20000801)40:4%3c336::AID-CYTO9%3e3.0.CO;2-0
   PubMedGoogle Scholar
• Gorski J, Yassai M, Zhu X, Kissela B, Kissella B, Keever C, Flomenberg N. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J Immunol 1994; 152:5109-19; PMID:8176227
   PubMed Web of Science ®Google Scholar
• Yew PY, Alachkar H, Yamaguchi R, Kiyotani K, Fang H, Yap KL, Liu HT, Wickrema A, Artz A, van Besien K, et al. Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2015; 50:1227-34; PMID:26052909; http://dx.doi.org/10.1038/bmt.2015.133
   PubMed Web of Science ®Google Scholar
• van Heijst JW, Ceberio I, Lipuma LB, Samilo DW, Wasilewski GD, Gonzales AM, Nieves JL, van den Brink MR, Perales MA, Pamer EG. Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation. Nat Med 2013; 19:372-7; PMID:23435170; http://dx.doi.org/10.1038/nm.3100
   PubMed Web of Science ®Google Scholar
• Du JW, Gu JY, Liu J, Cen XN, Zhang Y, Ou Y, Chu B, Zhu P. TCR spectratyping revealed T lymphocytes associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma 2007; 48:1618-27; PMID:17701594; http://dx.doi.org/10.1080/10428190701474357
   PubMed Web of Science ®Google Scholar
• Liu C, He M, Rooney B, Kepler TB, Chao NJ. Longitudinal analysis of T-cell receptor variable β chain repertoire in patients with acute graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12:335-45; PMID:16503503; http://dx.doi.org/10.1016/j.bbmt.2005.09.019
   PubMed Web of Science ®Google Scholar
• Ozdemir E, St John LS, Gillespie G, Rowland-Jones S, Champlin RE, Molldrem JJ, Komanduri KV. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. Blood 2002; 100:3690-7; PMID:12393402; http://dx.doi.org/10.1182/blood-2002-05-1387
   PubMed Web of Science ®Google Scholar
• de Oliveira LL, Coltri KC, Cardoso CR, Roque-Barreira MC, Panunto-Castelo A. T helper 1-inducing adjuvant protects against experimental paracoccidioidomycosis. PLoS Negl Trop Dis 2008; 2:e183; PMID:18335066; http://dx.doi.org/10.1371/journal.pntd.0000183
   PubMedGoogle Scholar
• Zhang Y, Wang F, Tompkins KC, McNamara A, Jain AV, Moore BB, Toews GB, Huffnagle GB, Olszewski MA. Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99. Am J Pathol 2009; 175:2489-500; PMID:19893050; http://dx.doi.org/10.2353/ajpath.2009.090530
   PubMed Web of Science ®Google Scholar
• Carvalho A, De Luca A, Bozza S, Cunha C, D'Angelo C, Moretti S, Perruccio K, Iannitti RG, Fallarino F, Pierini A, et al. TLR3 essentially promotes protective class I-restricted memory CD8(+) T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. Blood 2012; 119:967-77; PMID:22147891; http://dx.doi.org/10.1182/blood-2011-06-362582
   PubMed Web of Science ®Google Scholar
• Hebart H, Bollinger C, Fisch P, Sarfati J, Meisner C, Baur M, Loeffler J, Monod M, Latge JP, Einsele H. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies. Blood 2002; 100:4521-8; PMID:12393638; http://dx.doi.org/10.1182/blood-2002-01-0265
   PubMed Web of Science ®Google Scholar
• Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175:1459-66; PMID:9180187; http://dx.doi.org/10.1086/516480
   PubMed Web of Science ®Google Scholar
• Gratama JW, Brooimans RA, van der Holt B, Sintnicolaas K, van Doornum G, Niesters HG, Lowenberg B, Cornelissen JJ. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations. Cytometry B Clin Cytom 2008; 74:211-20; PMID:18454493; http://dx.doi.org/10.1002/cyto.b.20420
   PubMed Web of Science ®Google Scholar
• Lilleri D, Gerna G, Fornara C, Lozza L, Maccario R, Locatelli F. Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants. Blood 2006; 108:1406-12; PMID:16614242; http://dx.doi.org/10.1182/blood-2005-11-012864
   PubMed Web of Science ®Google Scholar
• Lamba R, Carrum G, Myers GD, Bollard CM, Krance RA, Heslop HE, Brenner MK, Popat U. Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab. Bone Marrow Transplant 2005; 36:797-802; PMID:16151431; http://dx.doi.org/10.1038/sj.bmt.1705121
   PubMed Web of Science ®Google Scholar
• Tey SK, Kennedy GA, Cromer D, Davenport MP, Walker S, Jones LI, Crough T, Durrant ST, Morton JA, Butler JP, et al. Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV(R) assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications. PLoS One 2013; 8:e74744; PMID:24146744; http://dx.doi.org/10.1371/journal.pone.0074744
   PubMed Web of Science ®Google Scholar
• Walker CM, van Burik JA, De For TE, Weisdorf DJ. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources. Biol Blood Marrow Transplant 2007; 13:1106-15; PMID:17697973; http://dx.doi.org/10.1016/j.bbmt.2007.06.006
   PubMed Web of Science ®Google Scholar
• Keever CA, Small TN, Flomenberg N, Heller G, Pekle K, Black P, Pecora A, Gillio A, Kernan NA, O'Reilly RJ. Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood 1989; 73:1340-50; PMID:2649174
   PubMed Web of Science ®Google Scholar
• Oshrine BR, Li Y, Teachey DT, Heimall J, Barrett DM, Bunin N. Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord blood. Biol Blood Marrow Transplant 2013; 19:1581-9; PMID:23939199; http://dx.doi.org/10.1016/j.bbmt.2013.08.003
   PubMed Web of Science ®Google Scholar
• Chae YS, Sohn SK, Kim JG, Cho YY, Moon JH, Yang DH, Lee JJ, Kim YK, Kim HJ, Shin HJ, et al. Impact of alemtuzumab as conditioning regimen component on transplantation outcomes in case of CMV-seropositive recipients and donors. Am J Hematol 2008; 83:649-53; PMID:18528826; http://dx.doi.org/10.1002/ajh.21215
   PubMed Web of Science ®Google Scholar
• Chakrabarti S, Mackinnon S, Chopra R, Kottaridis PD, Peggs K, O'Gorman P, Chakraverty R, Marshall T, Osman H, Mahendra P, et al. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. Blood 2002; 99:4357-63; PMID:12036862; http://dx.doi.org/10.1182/blood.V99.12.4357
   PubMed Web of Science ®Google Scholar
• Bernstein ID, Boyd RL, van den Brink MR. Clinical strategies to enhance posttransplant immune reconstitution. Biol Blood Marrow Transplant 2008; 14:94-9; PMID:18162228; http://dx.doi.org/10.1016/j.bbmt.2007.10.003
   PubMed Web of Science ®Google Scholar
• Seggewiss R, Einsele H. Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. Blood 2010; 115:3861-8; PMID:20215642; http://dx.doi.org/10.1182/blood-2009-12-234096
   PubMed Web of Science ®Google Scholar
• Zakrzewski JL, Kochman AA, Lu SX, Terwey TH, Kim TD, Hubbard VM, Muriglan SJ, Suh D, Smith OM, Grubin J, et al. Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nat Med 2006; 12:1039-47; PMID:16936725; http://dx.doi.org/10.1038/nm1463
   PubMed Web of Science ®Google Scholar
• Rice HE, Skinner MA, Mahaffey SM, Oldham KT, Ing RJ, Hale LP, Markert ML. Thymic transplantation for complete DiGeorge syndrome: medical and surgical considerations. J Pediatr Surg 2004; 39:1607-15; PMID:15547821; http://dx.doi.org/10.1016/j.jpedsurg.2004.07.020
   PubMed Web of Science ®Google Scholar
• Markert ML, Devlin BH, McCarthy EA. Thymus transplantation. Clin Immunol 2010; 135:236-46; PMID:20236866; http://dx.doi.org/10.1016/j.clim.2010.02.007
   PubMed Web of Science ®Google Scholar
• Barrett AJ, Bollard CM. The coming of age of adoptive T-cell therapy for viral infection after stem cell transplantation. Ann Transl Med 2015; 3:62; PMID:25992361
   PubMedGoogle Scholar